dr. manish shah discusses using stat 3 inhibitors to target cancer stem cells
Published 8 years ago • 167 plays • Length 0:50Download video MP4
Download video MP3
Similar videos
-
2:12
dr. manish shah on onartuzumab for gastroesophageal adenocarcinoma
-
7:36
angiogenesis in tumor growth and metastasis
-
22:52
drug discovery & endogenous stem cells - sendurai mani, ut md anderson center
-
10:00
novel agents for gastroesophageal cancer
-
1:40
dr. shah on risk factors for early-onset crc
-
16:02
part 5 - immunotherapy in the maintenance treatment of all patients with stage iii nsclc- dr manish
-
8:12
gastroesophageal cancer: emerging approaches
-
1:15
immunecode chapter 3 – a t-cell signature for covid-19 diagnostics
-
47:07
keynote: molecular regulation of stem cell quiescence & activation
-
10:45
immune surveillance - the third senotherapeutic strategy
-
2:18
als phase iii clinical trial
-
4:37
dr. milton b. armstrong, chief, division of plastic & reconstructive surgery - musc health
-
2:04
dr. eileen m. o'reilly on factors to consider in pancreatic cancer treatment
-
6:30
15 s3p1 singh
-
43:42
7 panel3 part1
-
2:48
what is a selective inhibitor of nuclear export (sine)?
-
6:30
15 s3p1 singh
-
1:00
endocrinology division | ssmc, abu dhabi
-
2:15
complete revascularization with multivessel pci in stemi study: phri